UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051965
Receipt number R000059105
Scientific Title Registry Research Study on Acute Encephalopathy and Febrile Convulsions
Date of disclosure of the study information 2023/08/22
Last modified on 2023/08/22 00:45:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Registry Research Study on Acute Encephalopathy and Febrile Convulsions

Acronym

Registry Research Study on Acute Encephalopathy and Febrile Convulsions

Scientific Title

Registry Research Study on Acute Encephalopathy and Febrile Convulsions

Scientific Title:Acronym

Registry Research Study on Acute Encephalopathy and Febrile Convulsions

Region

Japan Asia(except Japan)


Condition

Condition

acute encephalopathy, febrile seizure

Classification by specialty

Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Build-up of accumulated cases of acute encephalopathy, febrile convulsions, and status epilepticus

Basic objectives2

Others

Basic objectives -Others

follow-up of neurological outcomes

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

not applicable due to the nature of the study design.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

18 years-old >=

Gender

Male and Female

Key inclusion criteria

Persons who fulfill the following (1) and (2)
(i) Those who were hospitalized with a chief complaint of impaired consciousness/convulsions associated with fever, or with a final diagnosis of acute encephalopathy, or with status epilepticus.
(ii) Those who are between 1 month old and 18 years old (at the time of onset of illness)

Key exclusion criteria

(1) Patients who have requested not to participate in this study
(ii) Patients who are judged to be inappropriate as subjects by the principal investigator.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Nagase

Organization

Kobe University Graduate School of medicine

Division name

Department of Pediatrics

Zip code

6500017

Address

7-5-2 Kusunokucho, Chuo-ku, Kobe-shi

TEL

+8178-382-6090

Email

nagase@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Nagase

Organization

Kobe University Graduate School of medicine

Division name

Department of Pediatrics

Zip code

6500017

Address

7-5-2 Kusunokucho, Chuo-ku, Kobe-shi

TEL

+8178-382-6090

Homepage URL


Email

nagase@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

ministry of health labour and welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital, Clinical and translational research center.

Address

7-5-2 Kusunokucho, Chuo-ku, Kobe-shi

Tel

+8178-382-6669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 04 Month 16 Day

Date of IRB

2018 Year 04 Month 16 Day

Anticipated trial start date

2020 Year 01 Month 01 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A registry study describing the clinical course, laboratory findings, treatment, diagnoses, and outcomes of all eligible patients admitted to participating facilities.


Management information

Registered date

2023 Year 08 Month 22 Day

Last modified on

2023 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059105